No Known Direct Interactions
Vascepa (icosapent ethyl), a purified EPA omega-3 fatty acid used to lower triglycerides, has no documented pharmacokinetic or pharmacodynamic interactions with vitamin D in standard drug databases or prescribing information.[1][2] Clinical studies and post-marketing data do not report issues when taken together.
How Vascepa and Vitamin D Work
Vascepa reduces cardiovascular risk by targeting triglyceride-rich lipoproteins and inflammation, independent of vitamin D pathways. Vitamin D supports bone health, immunity, and calcium absorption via receptor binding. Their mechanisms do not overlap, minimizing interaction risk.[1][3]
What Studies and Databases Show
- FDA label for Vascepa lists interactions with drugs affecting coagulation or CYP3A4 (e.g., statins, fibrates), but not vitamins.[1]
- Tools like Drugs.com and WebMD interaction checkers flag no alerts for Vascepa + vitamin D.[2][4]
- Limited small studies on omega-3s and vitamin D focus on joint benefits for heart health or inflammation, with no adverse effects noted.[5]
Patient Considerations and Precautions
Patients on Vascepa should still consult doctors or pharmacists before adding supplements, as high-dose vitamin D (>4,000 IU daily) can affect calcium levels or interact indirectly with fish oil via bleeding risk if combined with anticoagulants.[3][6] Monitor for rare GI upset from either. No Vascepa-specific vitamin D warnings in patient guides.
Related Supplement Interactions with Vascepa
| Supplement | Potential Issue | Notes |
|------------|-----------------|-------|
| Vitamin E | Minor bleeding risk | High doses with Vascepa's antiplatelet effects.[2] |
| CoQ10 | None significant | Often paired safely with statins/Vascepa.[4] |
| Omega-3s (other) | Dose overlap | Avoid duplicating EPA intake.[1] |
Sources
[1]: FDA Vascepa Label
[2]: Drugs.com Interaction Checker
[3]: NIH Vitamin D Fact Sheet
[4]: WebMD Vascepa Interactions
[5]: PubMed Omega-3/Vit D Review
[6]: Mayo Clinic Statin-Supplement Guide